Cell Identity, Plasticity and Therapeutic Vulnerabilities in Cancer
Wednesday, January 27, 2027 at 11:30 AM to 12:00 PM · 30 min. (Europe/London)
Epigenetics & Translational Omics Stage
Day 1 - Wednesday 27th January
CancerEpigenetics
Information
- Understanding how targeted therapies induce cancer cell death and how these effects can be optimised
- Exploring how transcription factors such as MYC, p53 and RAS interact with epigenetic context to produce distinct outcomes across different cell types
- Investigating the role of cell identity and tumour plasticity in cancer progression and therapeutic response
- Understanding how cancer cells lose their normal cellular fate and how targeting MYC may help lock tumour cells into more stable states
- Addressing a central question in cancer biology: why the same signalling pathways can drive very different behaviours in different tissues
